|
End-of-day quote
Taipei Exchange
2026-08-25
|
5-day change | 1st Jan Change | ||
| 24.15 TWD | +0.21% |
|
+6.86% | -22.10% |
Company Valuation: Dexin Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 653.6 | 1,002 | 535 | 691.2 | 693.2 | 1,428 |
| Change | - | 53.29% | -46.6% | 29.21% | 0.29% | 106.02% |
| Enterprise Value (EV) 1 | 618 | 890.1 | 444.1 | 652.9 | 684.9 | 1,274 |
| Change | - | 44.02% | -50.11% | 47.04% | 4.9% | 86.07% |
| P/E | 30.8x | 16.6x | -10.3x | -7.29x | -16.4x | -30.3x |
| PBR | 1.76x | 2.33x | 1.23x | 1.99x | 2.28x | 4.13x |
| PEG | - | 0x | 0x | -0.1x | 0.3x | 11.64x |
| Capitalization / Revenue | 0.8x | 0.81x | 0.97x | 1.78x | 1.53x | 2.98x |
| EV / Revenue | 0.76x | 0.72x | 0.8x | 1.69x | 1.51x | 2.66x |
| EV / EBITDA | 19.5x | 10.7x | -8.81x | -6.68x | -13.5x | -141x |
| EV / EBIT | 33.9x | 12.7x | -6.85x | -5.76x | -10.1x | -49.3x |
| EV / FCF | -9.56x | 14x | -25.5x | -10.4x | -10.7x | 16.1x |
| FCF Yield | -10.5% | 7.14% | -3.92% | -9.65% | -9.33% | 6.22% |
| Dividend per Share 2 | 0.1586 | 0.7692 | - | - | - | - |
| Rate of return | 0.86% | 2.74% | - | - | - | - |
| EPS 2 | 0.6007 | 1.692 | -1.3 | -2.365 | -1.052 | -1.025 |
| Distribution rate | 26.4% | 45.5% | - | - | - | - |
| Net sales 1 | 813.5 | 1,231 | 552 | 387.4 | 454 | 479.3 |
| EBITDA 1 | 31.65 | 83.11 | -50.38 | -97.8 | -50.78 | -9.058 |
| EBIT 1 | 18.22 | 69.84 | -64.85 | -113.4 | -67.54 | -25.87 |
| Net income 1 | 21.38 | 60.16 | -50.76 | -94.78 | -42.16 | -43.89 |
| Net Debt 1 | -35.52 | -111.7 | -90.9 | -38.3 | -8.334 | -153.8 |
| Reference price 2 | 18.48 | 28.08 | 13.35 | 17.25 | 17.30 | 31.00 |
| Nbr of stocks (in thousands) | 35,357 | 35,682 | 40,072 | 40,072 | 40,072 | 46,071 |
| Announcement Date | 4/21/21 | 3/31/22 | 3/30/23 | 3/15/24 | 3/17/25 | 3/12/26 |
1TWD in Million2TWD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 3349 Stock
- Valuation Dexin Corporation
Select your edition
All financial news and data tailored to specific country editions
















